care clinic tirzepatide is FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Tirzepatide Treatment | Blue Skies

Zou, P., et al

These effects result directly from the medication's mechanism of actionspecifically, delayed gastric emptying and effects on gastrointestinal motility

The same is true for individual self-pay plans

If those first two sound familiar, it's because the current generation of weight loss medications already targets them

If youve been researching tirzepatide, youve probably noticed how hard it is to tell whos actually legit

Incidences of dysesthesia occurred in 5.1%, 12.3%, and 12.5% of patients treated with retatrutide 4 mg, 9 mg, and 12 mg, respectively, compared with 0.9% with placebo, and incidences of urinary tract infections occurred in 7.5%, 8.8%, and 8.4% of patients treated with retatrutide 4 mg, 9 mg, and 12 mg, respectively, compared with 5.3% with placebo